Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6874
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy ; volume:20 ; number:1 ; day:25 ; month:7 ; year:2020 ; pages:1-11 ; date:12.2020
BMC women's health ; 20, Heft 1 (25.7.2020), 1-11, 12.2020
- Urheber
-
Benning, Lorie
Mantsios, Andrea
Kerrigan, Deanna
Coleman, Jenell S.
Golub, Elizabeth
Blackstock, Oni
Konkle-Parker, Deborah
Philbin, Morgan
Sheth, Anandi
Adimora, Adaora A.
Cohen, Mardge H.
Seidman, Dominika
Milam, Joel
Kassaye, Seble G.
Taylor, Tonya
Murray, Miranda
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12905-020-01011-8
- URN
-
urn:nbn:de:101:1-2020092013340548166390
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Benning, Lorie
- Mantsios, Andrea
- Kerrigan, Deanna
- Coleman, Jenell S.
- Golub, Elizabeth
- Blackstock, Oni
- Konkle-Parker, Deborah
- Philbin, Morgan
- Sheth, Anandi
- Adimora, Adaora A.
- Cohen, Mardge H.
- Seidman, Dominika
- Milam, Joel
- Kassaye, Seble G.
- Taylor, Tonya
- Murray, Miranda
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Reversible Contraception
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Reversible Contraception
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Assessing readiness to implement long-acting injectable HIV antiretroviral therapy: provider and staff perspectives
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Reversible Contraception
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077